Tandem Diabetes Care Inc (NASDAQ: TNDM) open the trading on Wednesday, with a bit cautious approach as it glided -4.60% to $29.67, before settling in for the price of $31.10 at the close. Taking a more long-term approach, TNDM posted a 52-week range of $14.33-$53.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 36.59%. Meanwhile, its Annual Earning per share during the time was -6.11%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 50.65%. This publicly-traded company’s shares outstanding now amounts to $65.55 million, simultaneously with a float of $65.16 million. The organization now has a market capitalization sitting at $1.95 billion. At the time of writing, stock’s 50-day Moving Average stood at $38.05, while the 200-day Moving Average is $37.95.
Tandem Diabetes Care Inc (TNDM) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Devices industry. Tandem Diabetes Care Inc’s current insider ownership accounts for 0.79%, in contrast to 113.28% institutional ownership. According to the most recent insider trade that took place on May 30 ’24, this organization’s Director sold 5,000 shares at the rate of 51.68, making the entire transaction reach 258,400 in total value, affecting insider ownership by 0. Preceding that transaction, on Nov 27 ’23, Company’s Director bought 5,000 for 18.96, making the whole transaction’s value amount to 94,778. This particular insider is now the holder of 19,962 in total.
Tandem Diabetes Care Inc (TNDM) Earnings and Revenue Records
Tandem Diabetes Care Inc’s EPS increase for this current 12-month fiscal period is 50.65% and is forecasted to reach -1.21 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 38.80% through the next 5 years, which can be compared against the -6.11% growth it accomplished over the previous five years trading on the market.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Let’s observe the current performance indicators for Tandem Diabetes Care Inc (TNDM). It’s Quick Ratio in the last reported quarter now stands at 2.32. The Stock has managed to achieve an average true range (ATR) of 1.96. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.28.
In the same vein, TNDM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.94, a figure that is expected to reach -0.21 in the next quarter, and analysts are predicting that it will be -1.21 at the market close of one year from today.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
[Tandem Diabetes Care Inc, TNDM] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 17.83% While, its Average True Range was 1.96.
Raw Stochastic average of Tandem Diabetes Care Inc (TNDM) in the period of the previous 100 days is set at 1.90%, which indicates a major fall in contrast to 5.82% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 54.03% that was lower than 61.80% volatility it exhibited in the past 100-days period.
